文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

院前早期气道干预与院外心脏骤停患者结局的关联:TTM2试验的事后分析

Association between early airway intervention in the pre-hospital setting and outcomes in out of hospital cardiac arrest patients: A post-hoc analysis of the Target Temperature Management-2 (TTM2) trial.
PubMed 文献 · Resuscitation · 2024-09-05
一句话结论在TTM2试验的OHCA患者中,院前气管插管与声门上气道装置相比,未独立改善26天内无呼吸机天数、6个月神经功能结局或降低死亡率(HR 1.06,95%CI 0.88-1.28,p=0.54)。

本研究为TTM2试验的事后分析,纳入13个国家、1900例TTM2试验患者中的1702例(89.5%)成人院外心脏骤停且自主循环恢复、有院前气道管理数据的患者。院前气道管理为声门上气道装置者484例(28.4%),气管插管者1218例(71.6%)。入院时,声门上气道装置组87.8%、气管插管组98.5%接受机械通气(p<0.001)。多因素分析显示,与声门上气道装置相比,气管插管未独立增加随机化后26天内无呼吸机天数、未改善神经功能结局、未降低死亡率;气管插管 vs 声门上气道装置的死亡风险比HR 1.06,95%CI 0.88-1.28,p=0.54。结论认为院前气道装置选择与患者临床结局无独立关联。

要点

  • 在TTM2试验的OHCA患者中,院前气管插管与声门上气道装置相比,死亡风险比HR 1.06(95%CI 0.88-1.28,p=0.54),未达统计学显著。
  • 气管插管与声门上气道装置相比,未独立增加随机化后26天内无呼吸机天数,未独立改善6个月神经功能结局。
  • 入院时机械通气比例:声门上气道装置组87.8% vs 气管插管组98.5%(p<0.001)。
  • 院前气道管理方式:声门上气道装置484例(28.4%),气管插管1218例(71.6%),多数患者接受院前气管插管。
  • 多因素logistic回归采用后向逐步选择法,评估气管插管 vs 声门上气道装置与结局的关联。

适用人群与场景

  • 成人院外心脏骤停(OHCA)且自主循环恢复、有院前气道管理数据的患者,来自TTM2试验13个国家。
  • 共纳入1702例(占TTM2试验1900例的89.5%),平均年龄64岁(SD=13.53),男性79.1%。

处置流程与药物剂量

  • 院前气道管理方式:声门上气道装置484例(28.4%),气管插管1218例(71.6%)。
  • 入院时机械通气:声门上气道装置组87.8%,气管插管组98.5%(p<0.001)。

研究设计与关键结果

  • 研究类型:TTM2试验的事后分析(二次分析),多中心随机试验,13个国家。
  • 样本量:从TTM2试验1900例中纳入1702例(89.5%),平均年龄64岁(SD=13.53),男性79.1%。
  • 干预与对照:院前气管插管(1218例,71.6%) vs 声门上气道装置(484例,28.4%)。
  • 主要终点:多因素分析显示气管插管 vs 声门上气道装置未独立增加随机化后26天内无呼吸机天数、未独立改善6个月神经功能结局、未独立降低死亡率。
  • 死亡风险:气管插管 vs 声门上气道装置的HR 1.06,95%CI 0.88-1.28,p=0.54。
  • 入院时机械通气比例:声门上气道装置组87.8% vs 气管插管组98.5%(p<0.001)。

证据类型、等级与局限

  • 证据类型:多中心随机试验(TTM2)的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在纳入OHCA患者的TTM2多中心随机试验中,大多数患者接受院前气管插管管理气道;院前气道装置的选择与患者临床结局无独立关联。

指南或共识出处

  • Target Temperature Management-2 (TTM2) trial,试验注册号NCT02908308。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Airway management is a critical component of out-of-hospital cardiac arrest (OHCA) resuscitation. The primary aim of this study was to describe pre-hospital airway management in adult patients post-OHCA. Secondary aims were to investigate whether tracheal intubation (TI) versus use of supraglottic airway device (SGA) was associated with patients' outcomes, including ventilator-free days within 26 days of randomization, 6 months neurological outcome and mortality.

METHODS: Secondary analysis of the Target Temperature Management-2 (TTM2) trial conducted in 13 countries, including adult patients with OHCA and return of spontaneous circulation, with data available on pre-hospital airway management. A multivariate logistic regression model with backward stepwise selection was employed to assess whether TI versus SGA was associated with outcomes.

RESULTS: Of the 1900 TTM2 trial patients, 1702 patients (89.5%) were included, with a mean age of 64 years (Standard Deviation, SD = 13.53); 79.1% were males. Pre-hospital airway management was SGA in 484 (28.4%), and TI in 1218 (71.6%) patients. At hospital admission, 87.8% of patients with SGA and 98.5% with TI were mechanically ventilated (p < 0.001). In the multivariate analysis, TI in comparison with SGA was not independently associated with an increase in ventilator-free days within 26 days of randomization, improved neurological outcomes, or decreased mortality. The hazard ratio for mortality with TI vs. SGA was 1.06, 95%Confidence Interval (CI) 0.88-1.28, p = 0.54.

CONCLUSIONS: In the multicentre randomized TTM2-trial including patients with OHCA, most patients received prehospital endotracheal intubation to manage their airway. The choice of pre-hospital airway device was not independently associated with patient clinical outcomes.

TRIAL REGISTRATION NUMBER: NCT02908308.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Battaglini D, Schiavetti I, Ball L, et al. Association between early airway intervention in the pre-hospital setting and outcomes in out of hospital cardiac arrest patients: A post-hoc analysis of the Target Temperature Management-2 (TTM2) trial. Resuscitation. 2024. PMID: 39244144. doi:10.1016/j.resuscitation.2024.110390

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。